Latest Hemodialysis News
Large European study identifies ranges of phosphorus, calcium, and parathyroid hormone levels with the lowest death risk.
Fluid overload implicated as an important risk factor for hospital admission.
Daily home hemodialysis also decreases likelihood of hospitalization and technique failure.
African-American patients, however, had significantly higher intact parathyroid hormone levels, possibly due to lower 25-hydroxyvitamin D levels.
In a study, 45% of hemodialysis patients internationally reported skipping phosphate binder pills at least once in the prior month.
Hemodialysis patients who undergo the procedure experience decreased risks of all-cause and cardiovascular mortality.
New findings may support the notion that provider-level financial incentives influence decisions to start dialysis at higher levels of kidney function.
Two studies confirm the association, but it remains unclear whether correcting hypomagnesemia will lessen the likelihood of adverse outcomes.
Boiling sliced meat in a pressure cooker filled with soft water may be a promising way for dialysis patients to reduce phosphorus intake.
Training was effective at some time points in decreasing fluid, salt intake among those undergoing hemodialysis.
Cutting back on dietary phosphorus in addition to taking phosphate binders achieved greater decreases in serum phosphate in PD patients.
Hemodialysis patients treated with either agent have comparable risks of overall and cardiovascular mortality and cardiovascular events.
In a study, home hemodialysis was associated with a 53% decreased risk of death compared with peritoneal dialysis.
Lowest relative risk of death observed in patients with serum phosphorus and calcium levels of 4.4 mg/dL and 8.8 mg/dL, respectively.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)